Related references
Note: Only part of the references are listed.Revisiting Histone Deacetylases in Human Tumorigenesis: The Paradigm of Urothelial Bladder Cancer
Aikaterini F. Giannopoulou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells
Anna Wawruszak et al.
CANCERS (2019)
A proteolytic fragment of histone deacetylase 4 protects the heart from failure by regulating the hexosamine biosynthetic pathway
Lorenz H. Lehmann et al.
NATURE MEDICINE (2018)
Inflammation and renal fibrosis: Recent developments on key signaling molecules as potential therapeutic targets
Wenshan Lv et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Mining the Secretome of C2C12 Muscle Cells: Data Dependent Experimental Approach To Analyze Protein Secretion Using Label Free Quantification and Peptide Based Analysis
Leonie Grube et al.
JOURNAL OF PROTEOME RESEARCH (2018)
Effects of novel HDAC inhibitors on urothelial carcinoma cells
Aline Kaletsch et al.
CLINICAL EPIGENETICS (2018)
APOBEC3B Activity Is Prevalent in Urothelial Carcinoma Cells and On Slightly Affected by LINE-1 Expression
Ananda Ayyappan Jaguva Vasudevan et al.
FRONTIERS IN MICROBIOLOGY (2018)
Hypermethylation of miRNA-589 promoter leads to upregulation of HDAC5 which promotes malignancy in non-small cell lung cancer
Changhong Liu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
HDACs and HDAC Inhibitors in Urothelial Carcinoma - Perspectives for an Antineoplastic Treatment
Maria Pinkerneil et al.
CURRENT MEDICINAL CHEMISTRY (2017)
Transforming Growth Factor-β Is an Upstream Regulator of Mammalian Target of Rapamycin Complex 2-Dependent Bladder Cancer Cell Migration and Invasion
Sounak Gupta et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Inhibition of Class I Histone Deacetylases 1 and 2 Promotes Urothelial Carcinoma Cell Death by Various Mechanisms
Maria Pinkerneil et al.
MOLECULAR CANCER THERAPEUTICS (2016)
TGF-β: the master regulator of fibrosis
Xiao-ming Meng et al.
NATURE REVIEWS NEPHROLOGY (2016)
Regulation of class IIa HDAC activities: it is not only matter of subcellular localization
Eros Di Giorgio et al.
EPIGENOMICS (2016)
Piceatannol Attenuates Renal Fibrosis Induced by Unilateral Ureteral Obstruction via Downregulation of Histone Deacetylase 4/5 or p38-MAPK Signaling
Sin Young Choi et al.
PLOS ONE (2016)
The New Immortalized Uroepithelial Cell Line HBLAK Contains Defined Genetic Aberrations Typical of Early Stage Urothelial Tumors
Michele J. Hoffmann et al.
BLADDER CANCER (2016)
Identification of amino acid determinants in CYP4B1 for optimal catalytic processing of 4-ipomeanol
Constanze Wiek et al.
BIOCHEMICAL JOURNAL (2015)
The long noncoding RNA HOTAIR has tissue and cell type-dependent effects on HOX gene expression and phenotype of urothelial cancer cells
Judith Heubach et al.
MOLECULAR CANCER (2015)
Class IIa HDACs - new insights into their functions in physiology and pathology
Maribel Parra
FEBS JOURNAL (2015)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers
Guenter Niegisch et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2013)
HDAC5 is a novel injury-regulated tubulin deacetylase controlling axon regeneration
Yongcheol Cho et al.
EMBO JOURNAL (2012)
Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors
Genevieve P. Delcuve et al.
CLINICAL EPIGENETICS (2012)
Class IIa Histone Deacetylases Are Hormone-Activated Regulators of FOXO and Mammalian Glucose Homeostasis
Maria M. Mihaylova et al.
CELL (2011)
Histone deacetylases (HDACs) in XPC gene silencing and bladder cancer
Xiaoxin S. Xu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2011)
The many roles of histone deacetylases in development and physiology: implications for disease and therapy
Michael Haberland et al.
NATURE REVIEWS GENETICS (2009)
Share Paper
